For example, a study by Drucker et al. demonstrated that GLP-1 receptor agonists such as exenatide and liraglutide improve glycemic control and promote weight loss in patients with type 2 diabetes [15]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.